Interact to see
Advertisement
Advertisement
JMKCX vs MEDEX
JMKCX vs MEDEX Comparison
Open Charts JMKCX vs MEDEX
JHancock Emerging Markets Debt C
Price$8.13
Change+$0.01 (+0.12%)
VolumeN/A
Net Assets1.15B
MFS Emerging Markets Debt R2
Price$12.69
Change+$0.01 (+0.08%)
VolumeN/A
Net Assets7.63B
JMKCX vs MEDEX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
VS
JMKCX vs. MEDEX commentary
Nov 20, 2025
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JMKCX is a Hold and MEDEX is a Hold.
FUNDAMENTALS
Fundamentals
MEDEX has more cash in the bank: 7.63B vs. JMKCX (1.15B). JMKCX (4.87) and MEDEX (4.85) have matching dividends . JMKCX was incepted earlier than MEDEX: JMKCX (11 years) vs MEDEX (17 years). JMKCX (1.89) is less costly to investors than MEDEX (1.32). MEDEX has a lower initial minimum investment than JMKCX: MEDEX (0) vs JMKCX (1000). MEDEX annual gain was more profitable for investors over the last year : 10.23 vs. JMKCX (9.52). JMKCX return over 5 years is better than : 9.53 vs. MEDEX (9.04).
| JMKCX | MEDEX | JMKCX / MEDEX | |
| Total Expense Ratio | 1.88 | 1.31 | 144% |
| Annual Report Gross Expense Ratio | 1.89 | 1.32 | 143% |
| Fund Existence | 11 years | 17 years | - |
| Gain YTD | 9.556 | 10.092 | 95% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 1000 | 0 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 1.15B | 7.63B | 15% |
| Annual Yield % from dividends | 4.87 | 4.85 | 100% |
| Returns for 1 year | 9.52 | 10.23 | 93% |
| Returns for 3 years | 34.22 | 33.64 | 102% |
| Returns for 5 years | 9.53 | 9.04 | 105% |
| Returns for 10 years | 42.27 | 43.10 | 98% |
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement